World Infection Prevention Product Demand to Reach $130 Million

World demand for infection prevention products is forecast to increase 6.4 percent annually to $130 billion in 2017.  The upgrading and enforcement of patient and staff safety standards in health care facilities, coupled with an expanding volume of hospital, surgical, and outpatient procedures, will promote overall gains.  China, the United States, India, Russia, Japan, Germany, France, Italy, Brazil, and the United Kingdom will comprise the 10 largest national markets, combining to account for nearly two-thirds of global demand in 2017.  These and other trends, including market share and product segmentation, are presented in World Infection Prevention Products, a new study from The Freedonia Group, Inc., a Cleveland-based industry market research firm.

Demand for infection prevention products in the United States, Western Europe, Japan, and virtually all other developed countries will expand at a below average pace through 2017 and beyond as their medical delivery systems are well established, meet the health care needs of most residents, and have already adopted stringent patient and medical staff safety standards.  By contrast, growth in China, India, Brazil, and many other emerging economies will exceed the world average as their health care sectors are expanded, modernized, and adapted to formal infection prevention protocols.

Protective apparel and textiles will remain the top selling group of infection prevention products worldwide.  Expanded efforts by hospitals and outpatient facilities to reduce the threat of health care-associated infections (HAIs) in operating rooms will promote the increasing use of high value-added, barrier enhanced surgical drapes, gowns, face masks, and other apparel.  Safety enhanced medical devices will also fare well in the global marketplace as health care facilities seek improved safety in blood collection, catheterization, drug delivery, and surgical procedures.  This product group serves two critical areas of infection prevention:  the reduction of HAIs and the prevention of accidental needlesticks.

The Freedonia Group is a leading international business research company, founded in 1985, that publishes more than 100 industry research studies annually. This industry analysis provides an unbiased outlook and a reliable assessment of an industry and includes product segmentation and demand forecasts, industry trends, demand history, threats and opportunities, competitive strategies, market share determinations and company profiles.